Abhishek Thavamani

Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity

Anuradha Chougule, Kumar Prabhash, Vanita Noronha et al. · PLoS ONE · 2013 · 126 citations · Full text

EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy

Vanita Noronha, Kumar Prabhash, Abhishek Thavamani et al. · PLoS ONE · 2013 · 83 citations · Full text

Egfr Targeted Therapy, Pathology, Egfr Mutations +16

PARP-inhibition reprograms macrophages toward an anti-tumor phenotype

Lin Wang, Dan Wang, Olmo Sonzogni et al. · Cell Reports · 2022 · 52 citations · Full text

Breast Oncology, Parp-inhibition Reprograms, Medicine +14

The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma

Constanze Hermanns, V Hampl, Kerstin Hölzer et al. · Oncogene · 2017 · 46 citations · Full text

Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer

Anuradha Choughule, Rashmi Sharma, Vaishakhi Trivedi et al. · British Journal of Cancer · 2014 · 44 citations · Full text